CRIS

Curis

1.110

+0.396+55.48%

After Hours: 0.8699 -0.2401 -21.63%19:59 11/04 EST

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE1.350/0.7139

TODAY RANGE1.060-1.600

VOL163.53M

MARKET CAP4.56M

52 WEEK RANGE0.3250-31.80

AVG VOL (3M)3.73M

% TURNOVER3,881.01%

TURNOVER--

P/E (TTM)-0.0775

% RANGE75.64%

EPS(TTM)-14.3309

P/E(FORWARD)-0.0467

P/B0.4608

BVPS2.409

DIVIDEND--

P/S0.0760

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP4.38M

SHARES OUTSTANDING4.10M

NEXT EARNINGS11/05-11/09

FREE FLOAT3.95M

LOT SIZE1

EX-DATE07/06/2026

News

Press Releases

Financial Reports

Profile

TipRanks·10/19 21:02
Curis Secures PIPE Financing Through Securities Purchase Agreement
Seeking Alpha·10/16 12:31
Curis prices $8.5M private placement offering
TipRanks·10/16 12:06
Curis announces $8.5M private placement
Dow Jones·10/16 12:00
Press Release: Curis, Inc. Announces Pricing of $8.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules with Existing Healthcare Focused Institutional Investors
Dow Jones·10/16 12:00
*Curis Prices $8.5 M Private Placement Priced At-the-Market With Existing Healthcare Focused Institutional Investors
TipRanks·08/17 11:40
Analysts Are Bullish on These NA Stocks: Curis (CRIS), Canadian National Railway (CNI)
TipRanks·08/16 06:01
Curis Inc.’s 1-for-20 Reverse Split Raises Liquidity Concerns and Odd-Lot Trading Risks
Seeking Alpha·08/13 12:40
Curis prices $5.6 million public offering
TipRanks·08/10 21:35
Curis files to sell 3.73M shares of common stock, warrants
TipRanks·07/30 21:20
Curis Regains Nasdaq Compliance, Faces One-Year Monitoring
TipRanks·07/29 17:40
Analysts Offer Insights on Healthcare Companies: Tenaya Therapeutics (TNYA), Bausch + Lomb Corporation (BLCO) and Curis (CRIS)
Dow Jones·07/24 10:24
Curis Price Target Raised to $43.00/Share From $17.00 by HC Wainwright & Co.
Dow Jones·07/24 10:24
Curis Is Maintained at Buy by HC Wainwright & Co.
TipRanks·07/24 10:06
Curis price target raised to $43 from $17 at H.C. Wainwright
TipRanks·07/22 11:05
Curis to report clinical data in the TakeAim Lymphoma study

Same Industry

Name/Symbol

Change%

Price

CRIS

Regeneron Pharmaceuticals

REGN

+3.60%

961.26

GRDX

BNTX

UTHR

Siga Technologie

SIGA

-4.40%

3.040

Vertex Pharmaceuticals Inc

VRTX

-1.03%

553.15

Moderna

MRNA

-0.47%

221.72

Charles Riv Labs Intl Inc

CRL

-4.44%

359.41

Medpace Holdings

MEDP

-1.01%

656.77

Talphera Inc

TLPH

+0.96%

1.050

ICON plc

ICLR

-1.91%

211.36

China Biologic

CBPO

0.00%

119.99

IQV

MOLN

Arcturus Therape

ARCT

+13.94%

10.87

GILD

PRA Health

PRAH

0.00%

165.21

APVO

Incyte Corp

INCY

+3.07%

120.39

Biospecifics

BSTC

+0.15%

88.53

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.